These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31011874)

  • 1. The clinicopathological characteristics and prognostic value of squamous differentiation in patients with bladder urothelial carcinoma: a meta-analysis.
    Lin X; Deng T; Wu S; Lin SX; Wang D; Wu CL
    World J Urol; 2020 Feb; 38(2):323-333. PubMed ID: 31011874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder.
    Minato A; Noguchi H; Tomisaki I; Fukuda A; Kubo T; Nakayama T; Fujimoto N
    Cancer Control; 2018; 25(1):1073274818800269. PubMed ID: 30213195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of squamous histology in bladder cancer: a population-based study.
    Izard JP; Siemens DR; Mackillop WJ; Wei X; Leveridge MJ; Berman DM; Peng Y; Booth CM
    Urol Oncol; 2015 Oct; 33(10):425.e7-13. PubMed ID: 26199176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmacytoid Variant Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-Analysis of Clinicopathological Features and Survival Outcomes.
    Kim DK; Kim JW; Ro JY; Lee HS; Park JY; Ahn HK; Lee JY; Cho KS
    J Urol; 2020 Aug; 204(2):215-223. PubMed ID: 32003614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review and Meta-Analysis of Variant Histology in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy.
    Mori K; Abufaraj M; Mostafaei H; Quhal F; Karakiewicz PI; Briganti A; Kimura S; Egawa S; Shariat SF
    J Urol; 2020 Dec; 204(6):1129-1140. PubMed ID: 32716694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinicopathological and prognostic value of PD-L1 in urothelial carcinoma: a meta-analysis.
    Wen Y; Chen Y; Duan X; Zhu W; Cai C; Deng T; Zeng G
    Clin Exp Med; 2019 Nov; 19(4):407-416. PubMed ID: 31407099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
    Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
    BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squamous or Glandular Differentiation Predicts Poor Prognosis in pT1 Urothelial Carcinoma.
    Nakagawa R; Iwamoto H; Makino T; Kadomoto S; Yaegashi H; Shigehara K; Izumi K; Kadono Y; Mizokami A
    In Vivo; 2022; 36(5):2365-2370. PubMed ID: 36099139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
    Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M
    Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
    Kim SP; Frank I; Cheville JC; Thompson RH; Weight CJ; Thapa P; Boorjian SA
    J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squamous Differentiation Predicts Poor Response to Cisplatin-Based Chemotherapy and Unfavorable Prognosis in Urothelial Carcinoma of the Urinary Bladder.
    Minato A; Fujimoto N; Kubo T
    Clin Genitourin Cancer; 2017 Dec; 15(6):e1063-e1067. PubMed ID: 28803791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant carcinoma in situ may not be a prognostic factor for patients with bladder cancer following radical cystectomy: a PRISMA-compliant systematic review and meta-analysis.
    Zhang L; Wu B; Zha Z; Zhao H; Yuan J; Jiang Y
    World J Urol; 2020 Jan; 38(1):129-142. PubMed ID: 30919100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sp1 is overexpressed and associated with progression and poor prognosis in bladder urothelial carcinoma patients.
    Zhu J; Lu Z; Ke M; Cai X
    Int Urol Nephrol; 2022 Jul; 54(7):1505-1512. PubMed ID: 35467245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological characteristics and prognostic indicators of different histopathological types of urinary bladder cancer following radical cystectomy in a large single-center Egyptian cohort.
    Martin JW; Vernez SL; Lotan Y; Abdelhalim A; Dutta R; Shokeir A; Abol-Enein H; Mosbah A; Ghoneim M; Youssef RF
    World J Urol; 2018 Nov; 36(11):1835-1843. PubMed ID: 29761225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological factors in bladder cancer for cancer-specific survival outcomes following radical cystectomy: a systematic review and meta-analysis.
    Zhang L; Wu B; Zha Z; Qu W; Zhao H; Yuan J
    BMC Cancer; 2019 Jul; 19(1):716. PubMed ID: 31324162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic values of the clinicopathological characteristics and survival outcomes in micropapillary urothelial carcinoma of the bladder: A SEER database analysis.
    Jin D; Jin K; Qiu S; Zhou X; Yuan Q; Yang L; Wei Q
    Cancer Med; 2020 Jul; 9(14):4897-4906. PubMed ID: 32529761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients.
    Moschini M; Shariat SF; Lucianò R; D'Andrea D; Foerster B; Abufaraj M; Bandini M; Dell'Oglio P; Damiano R; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A
    Clin Genitourin Cancer; 2017 Aug; 15(4):e603-e607. PubMed ID: 28040422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
    Xylinas E; Rink M; Robinson BD; Lotan Y; Babjuk M; Brisuda A; Green DA; Kluth LA; Pycha A; Fradet Y; Faison T; Lee RK; Karakiewicz PI; Zerbib M; Scherr DS; Shariat SF
    Eur J Cancer; 2013 May; 49(8):1889-97. PubMed ID: 23466126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder.
    Wang B; Wu S; Zeng H; Liu Z; Dong W; He W; Chen X; Dong X; Zheng L; Lin T; Huang J
    J Urol; 2015 Aug; 194(2):556-62. PubMed ID: 25752441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micropapillary Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-analysis of Disease Characteristics and Treatment Outcomes.
    Abufaraj M; Foerster B; Schernhammer E; Moschini M; Kimura S; Hassler MR; Preston MA; Karakiewicz PI; Remzi M; Shariat SF
    Eur Urol; 2019 Apr; 75(4):649-658. PubMed ID: 30553613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.